Back to results
US 2023/0141355 A1Published application
Cxcl8 inhibitors for use in the treatment of covid-19
AssigneeDompé Farmaceutici S.P.A.
InventorsMarcello ALLEGRETTI, Flavio MANTELLI, Lorenzo PIEMONTI
Life of this patent
Estimating the term…
Abstract
The present invention relates to CXCL8 inhibitors for use in the treatment of COVID-19 patients with pneumonia.
Claims29
A method for treating a patient with COVID-19 pneumonia, the method comprising administering a CXCL8 inhibitor to the patient.
(canceled)
Dependencies are inferred from the claim text.